As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
The call for papers for our upcoming special issue on ‘Targeting cancer evolution in the clinic’, guest edited by Razelle Kurzrock and Alberto Bardelli is now open.
Jakob Skou Pedersen and colleagues generate a catalog of circRNA-RBP interactions in ENCODE cell lines and find that these could play a regulatory role in bladder cancer.
Reviews, Research Highlights and Commentaries
Focus: the Gut Microbiome
Read the latest papers on gut microbiota and disease across BMC flagship journals.
Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies
Zengliang Jiang et al.
Published in BMC Medicine 03 December 2020
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Federico Baldini et al.
Published in BMC Biology 09 June 2020
Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
Hechen Huang et al.
Published in Genome Medicine 23 November 2020
Lifestyle and the presence of helminths is associated with gut microbiome composition in Cameroonians
Meagan A. Rubel et al.
Published in Genome Biology 25 May 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
A decade of Genome Medicine
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
From the blog
01 December 2020
12 November 2020
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.